Investing
Payments for (Proceeds from) Derivative Instrument, Investing Activities
ResMed Payments for (Proceeds from) Derivative Instrument, Investing Activities decreased by 294.1% to -$24.07M in Q1 2026 compared to the prior quarter.
Analysis
StatementCash Flow Statement
SectionInvesting
First reportedQ1 2014
Last reportedQ3 2026Apr 30, 2026
Metric ID:
investing_payments_for_proceeds_from_derivative_instrume_2c4231Historical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.48M | $1.94M | $0 | $11.87M | $3.04M | -$10.22M | -$11.78M | $1.5M | $5.46M | $4.58M | -$18.98M | -$40.41M | $4.1M | $12.41M | -$24.07M |
| QoQ Change | — | -44.3% | -100.0% | — | -74.4% | -436.1% | -15.2% | +112.7% | +263.4% | -16.1% | -514.6% | -112.9% | +110.2% | +202.3% | -294.1% |
| YoY Change | — | — | — | — | -12.6% | -627.5% | — | -50.7% | +153.4% | +138.9% | <-999% | — | +121.6% | — | — |
Range-$40.41M – $12.41M
CAGR+73.8%
Avg YoY Growth-234.4%
Median YoY Growth-12.6%
Payments for (Proceeds from) Derivative Instrument, Investing Activities at Other Companies
Frequently Asked Questions
- What is ResMed's payments for (proceeds from) derivative instrument, investing activities?
- ResMed (RMD) reported payments for (proceeds from) derivative instrument, investing activities of -$24.07M in Q1 2026.